Navigation Links
Provia Labs’ Store-A-Tooth™ Announces Top Expert in Stem Cell Biobanking as its Scientific Advisor

Lexington, MA (PRWEB) December 18, 2012

Provia Labs’ Store-A-Tooth™, a leader in dental stem cell banking, announces the appointment of Joseph C. Laning, PhD as Scientific Advisor to the company. Dr. Laning brings over 17 years of experience in the fields of regenerative medicine, cellular and molecular immunology, and industry experience in biomedical research. He is currently the Senior Director of the Massachusetts Stem Cell Bank and Registry at the University of Massachusetts Medical School, an initiative funded in partnership with the Massachusetts Life Sciences Center.

Dr. Laning will serve as scientific advisor to Provia Labs in areas relating to stem cell therapy research and development, regenerative science and biobanking protocols. An accomplished speaker, he will also be available to give scientific presentations on stem cell science to dental and medical professionals. At a press conference hosted by Provia Labs at last year’s Chicago Dental Society (CDS) mid-winter meeting, Dr. Laning gave an overview of current research into clinical stem cell applications to a gathering of dental trade media.

“We’re pleased to have such a well-regarded stem cell expert join forces with Store-A-Tooth. Joe Laning brings expertise in biobanking as well as research and development in cell therapy and immunobiology that will enhance our scientific knowledge and capabilities,” said Peter Verlander, PhD, Chief Scientific Officer at Provia Labs. “His role leading the Massachusetts Stem Cell Bank at UMass Medical enables Provia Labs to tap into the state of the art in scientific discovery that may lead to new stem cell therapeutics.”

Dr. Joseph Laning joins Provia Labs as a Scientific Advisor after 17 years as an experienced executive, manager and scientist in the fields of regenerative medicine, wound care and cell therapy. He began his career at Organogenesis, Inc. where he developed and implemented pre-clinical investigations and subsequently managed all patient immunology safety testing leading to the PMA approval of Apligraf™. In 2002, he joined ViaCell, Inc. where he served as Director of Therapeutic Development and subsequently Senior Director of Analytical Biology, overseeing the company’s cell therapy development program. ViaCell was acquired in 2007 by PerkinElmer, which now is a leader in the cord blood banking industry under the name ViaCord®.

Dr. Laning managed scientific efforts as part of joint ventures with Amgen, J&J, and Alnylam investigating combinatorial stem cell product development initiatives in cardiac repair and hematopoietic reconstitution. Dr. Laning received his BA in Biology from Boston University and his PhD in Immunology from Harvard University.

According to Howard Greenman, CEO of Provia Labs, “Dr. Laning’s appointment as Scientific Advisor underscores our commitment to provide scientific rigor and the highest level of quality for Store-A-Tooth, our dental stem cell banking service. Our goal is to make dental stem cell preservation a simple process for patients and dentists alike, while the technology we provide behind the scenes reflects industry-leading protocols for cell culturing, biobanking and cryopreservation.”

About Provia Laboratories, LLC
Provia Laboratories, LLC ( is a health services company specializing in high quality biobanking (the collection, transport, processing, and cryogenic storage of biological specimens). Its dental stem cell banking service, Store-A-Tooth™, gives parents the option to store stem cells today to protect their children’s health tomorrow. Store-A-Tooth preserves precious stem cells from baby and wisdom teeth that would otherwise be discarded, so parents can be prepared for advances in stem cell therapies that someday may help treat conditions such as type 1 diabetes, spinal cord injury, heart attack, stroke, and neurological disorders like Parkinson’s and Alzheimer’s.

For more information about Store-A-Tooth™ dental stem cell banking, please call 1-877-867-5753 or visit us at or ‘Like’ Store-A-Tooth at To learn more about their ‘Stem Cells for a Cure’ initiative to support diabetes research, visit

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Provia Labs Hires Vice President of International Business Development to Expand Global Distribution for its Stem Cell Banking Service and Biobanking Products
2. Store-A-Tooth™ Dental Stem Cell Banking Announces Appointment of Dedicated Representative in South Florida
3. Ramey & Browning Announces New Location and New Hire Firm Is Well Positioned to Address Growing Client Needs In 2013
4. DTRA/SCC-WMD Announces $1 Million Algorithm Challenge
5. Galileo Analytics Announces Agreement to Provide Analytic Component of ASCOs CancerLinQ Prototype
6. Accelr8 Announces NASDAQ Capital Market Listing
7. XBiotech Announces Positive Phase II Clinical Trial Results for Lead Candidate MABp1 in Acne Vulgaris
8. Milo Biotechnology Announces FDA Orphan Drug Designation for AAV1-FS344 for Treatment of Duchenne and Becker Muscular Dystrophy
9. Career Confidential Announces Release of New E-book About Using Recruiters
10. Pittcon Announces 2013 Award Recipients; New Award, Robert Boyle Prize for Analytical Science, Added to Technical Program
11. Innosight Announces Leadership Transition
Post Your Comments:
(Date:11/24/2015)... 24, 2015 /CNW/ - iCo Therapeutics ("iCo" or "the ... results for the quarter ended September 30, 2015. ... dollars and presented under International Financial Reporting Standards ... ," said Andrew Rae , President & ... are not only value enriching for this clinical ...
(Date:11/24/2015)... 24, 2015  Clintrax Global, Inc., a worldwide provider of clinical ... today announced that the company has set a new quarterly earnings ... on quarter growth posted for Q3 of 2014 to Q3 of ... Mexico , with the establishment of an ... --> United Kingdom and Mexico ...
(Date:11/24/2015)... Massachusetts , November 24, 2015 SHPG ... will participate in the Piper Jaffray 27 th Annual Healthcare ... Tuesday, December 1, 2015, at 8:30 a.m. EST (1:30 p.m. GMT). ... , Chief Financial Officer, will participate in the Piper Jaffray 27 ... , NY on Tuesday, December 1, 2015, at 8:30 a.m. ...
(Date:11/24/2015)... , Nov. 24, 2015  Twist Bioscience, a ... Emily Leproust, Ph.D., Twist Bioscience chief executive officer, ... Conference on December 1, 2015 at 3:10 p.m. ... York City. --> ... . Twist Bioscience is on Twitter. Sign up ...
Breaking Biology Technology:
(Date:11/2/2015)... , Nov. 2, 2015  SRI International has been ... provide preclinical development services to the National Cancer Institute ... will provide scientific expertise, modern testing and support facilities, ... preclinical pharmacology and toxicology studies to evaluate potential cancer ... The PREVENT Cancer Drug Development Program is an ...
(Date:10/29/2015)... 2015  The J. Craig Venter Institute (JCVI) policy ... and Biosecurity: Lessons Learned and Options for the Future," ... Human Services guidance for synthetic biology providers has worked ... --> --> Synthetic biology promises ... to pose unique biosecurity threats. It now is easier ...
(Date:10/29/2015)... 29, 2015  Rubicon Genomics, Inc., today announced ... of its DNA library preparation products, including the ... ThruPLEX Plasma-seq kit. ThruPLEX Plasma-seq has been optimized ... NGS libraries for liquid biopsies--the analysis of cell-free ... applications in cancer and other conditions. Eurofins Scientific ...
Breaking Biology News(10 mins):